Erik C. B. Johnson

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease

  Alzheimer s & Dementia · 2025-12-01

• CSF Proteomics and Machine Learning Reveal Distinct Stages Across the Alzheimer’s Disease ContinuumPreprint

  medRxiv · 2025-11-13 · 1 citations

• Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer’s and related dementias

  npj Dementia · 2025-11-03 · 3 citations

• Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers

  Alzheimer s & Dementia · 2025-11-01 · 3 citations

• Cerebrospinal fluid proteomics for predictive assessment of Alzheimer’s Disease riskPreprint

  medRxiv · 2025-10-27 · 1 citations

• Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer’s disease riskPreprint

  medRxiv · 2025-10-13 · 3 citations

• Multiscale proteomic modeling reveals protein networks driving Alzheimer’s disease pathogenesis

  Cell · 2025-09-25 · 19 citations

• Plasma proteomic associations with Alzheimer’s disease endophenotypes

  Nature Aging · 2025-09-10 · 8 citations

• The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging

  Nature Medicine · 2025-07-15 · 88 citations

• Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

  Nature Aging · 2025-07-07

• Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

  Alzheimer s & Dementia · 2025-07-01 · 4 citations

• Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

  Nature Communications · 2025-07-01 · 11 citations

• Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

  Nature Aging · 2025-05-16 · 8 citations

• The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease

  Journal of Alzheimer s Disease · 2025-04-21 · 6 citations

• Amyloid <scp>PET</scp> in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the <scp>LEADS</scp> and <scp>ADNI</scp> Cohorts

  Annals of Neurology · 2025-03-17 · 11 citations

• Proteomic Subtyping of Alzheimer’s Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic BiomarkersPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-03-15 · 4 citations

• Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials

  The Journal of Prevention of Alzheimer s Disease · 2025-02-16 · 6 citations

• Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia

  Nature Medicine · 2025-02-10 · 22 citations

• Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach

  Alzheimer s Research & Therapy · 2025-02-06 · 9 citations

• Dissociable spatial topography of cortical atrophy in early‐onset and late‐onset Alzheimer's disease: A head‐to‐head comparison of the LEADS and ADNI cohorts

  Alzheimer s & Dementia · 2025-02-01 · 8 citations